UBS O'Connor’s AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share AEON.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-74,997
| Closed | -$114K | – | 591 |
|
|
2024
Q1 | $114K | Hold |
74,997
| – | – | ﹤0.01% | 382 |
|
|
2023
Q4 | $6.56K | Sell |
74,997
-33,921
| -31% | -$2.97K | ﹤0.01% | 401 |
|
|
2023
Q3 | $17.4K | Hold |
108,918
| – | – | ﹤0.01% | 436 |
|
|
2023
Q2 | $9.26K | Sell |
108,918
-3,555
| -3% | -$302 | ﹤0.01% | 484 |
|
|
2023
Q1 | $7.38K | Buy |
+112,473
| New | +$7.38K | ﹤0.01% | 545 |
|
|
2022
Q4 | – | Sell |
-112,473
| Closed | -$8K | – | 475 |
|
|
2022
Q3 | $8K | Sell |
112,473
-11,307
| -9% | -$804 | ﹤0.01% | 867 |
|
|
2022
Q2 | $19K | Buy |
+123,780
| New | +$19K | ﹤0.01% | 867 |
|
|
2022
Q1 | – | Sell |
-171,253
| Closed | -$87K | – | 331 |
|
|
2021
Q4 | $87K | Buy |
171,253
+4,593
| +3% | +$2.33K | ﹤0.01% | 822 |
|
|
2021
Q3 | $95K | Hold |
166,660
| – | – | ﹤0.01% | 800 |
|
|
2021
Q2 | $171K | Buy |
+166,660
| New | +$171K | ﹤0.01% | 731 |
|